Pharmaceutical marketing – News, Research and Analysis – The Conversation

The way opioid drugs were marketed to doctors may have contributed to the opioid crisis. AP Photo/Mark Lennihan

March 9, 2020

Opioid marketing to Canadian doctors hyped benefits, downplayed harms

Joel Lexchin, University of Toronto and Barbara Mintzes, University of Sydney

Aggressive marketing of prescription opioids by pharmaceutical companies provided doctors with scant information about potential harmful effects.

Doctors’ prescribing habits are influenced by drug reps and other industry marketing. Monkey Business Images/Shutterstock

December 3, 2019

Time to end drug company distortion of medical evidence

Ray Moynihan, Bond University

Too often, pharmaceutical companies and device manufacturers exert influence in how their products are tested in the research phase and recommended in the clinic.

The Chronic Pain Association of Canada has received money from Eli Lilly Canada Inc., Purdue Canada Inc. and Merck Frosst Canada. A blog post on the association’s website contains messages favourable to increased opioid use. (Flickr/Ajay Suresh)

January 16, 2019

Why Big Pharma must disclose payments to patient groups

Itai Bavli, University of British Columbia and Joel Lexchin, University of Toronto

Evidence shows that opioid manufacturers fund patient advocacy groups in Canada, distorting policies to protect public health.

The Family Medicine Forum, Nov. 9, 2017, the Palais des congrès de Montréal. (Twitter/@FamilyMedForum)

November 13, 2018

Family doctors are overdosing on industry sponsorship

Sarah Giles, L’Université d’Ottawa/University of Ottawa

This week’s annual Family Medicine Forum is an opportunity for your family doctor – to cave or resist in the face of Big Pharma sponsorship and marketing.

Articles on Pharmaceutical marketing

Displaying all articles